CGCCanopy Growth Corporation

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · canopygrowth.com

1.050USDMkt Cap: 499.34M $P/E: —3d ago

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and …

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.19BUSDP/E 23.7

TAK

Takeda Pharmaceutical Co. Ltd.

$58.06BUSD

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$43.98BUSDP/E 20.4

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

Neurocrine Biosciences, Inc.

$15.51BUSDP/E 22.3

ELAN

Elanco Animal Health Incorporat

$11.98BUSD

RDY

Dr. Reddy's Laboratories Ltd

Hims & Hers Health, Inc.

$7.88BUSD

LNTH

Lantheus Holdings Inc

$6.53BUSDP/E 23.9

AMRX

Amneal Pharmaceuticals, Inc. Class A

Kiniksa Pharmaceuticals, Ltd.

$6.08BUSDP/E 79.8

Key Statistics

Company

Market Cap499.34M $

Enterprise Value383.71M $

Revenue (TTM)293.63M $

Gross Profit69.67M $

Net Income (TTM)-262.91M $

Revenue/Share0.8240 USD

Last Price1.050 USD

Fiscal Year EndMar 2026

MR QuarterJun 2026

Employees1.1K

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISINCA1380351009

Valuation

P/E (Trailing)—

P/E (Forward)-8.51

PEG—

EV/EBITDA-14.70

EV/Revenue1.31

P/S1.70

P/B0.89

EPS (TTM)-0.49

EPS (Forward)-0.12

52W Range

1.0500% of range1.080

52W High1.080 USD

52W Low1.050 USD

Profitability

Gross Margin24.48%

Oper. Margin-21.66%

EBITDA Margin-8.89%

Profit Margin-92.38%

ROE-37.69%

ROA-23.50%

Growth

Revenue Growth12.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF-63.81M $

CapEx (TTM)5.95M $

FCF Margin2.45%

FCF Yield1.44%

Net Debt-60.48M $

Net Debt/EBITDA2.32

Balance Sheet

Debt/Equity0.40

Current Ratio3.04

Quick Ratio2.28

Book Value/Sh1.182 USD

Cash/Share0.7990 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:10

Split DateDec 20, 2023

Analyst Consensus

Rating2.5 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)1.233 USD

Upside (mean)+17.4%

Target Range1.233 USD – 1.233 USD

# Analysts1

Ownership

Shares Out.423.04M

Float422.23M

Insiders0.19%

Institutions7.92%

Short Interest

Short Ratio7.9d

Short % Float5.90%

Short % Out.5.90%

Shares Short24.90M

Short (prev mo.)23.74M

Technical

SMA 500.9595 (+9.4%)

SMA 2001.091 (-3.7%)

Beta2.41

S&P 52W Chg19.18%

Avg Vol (30d)5.36M

Avg Vol (10d)5.28M

Technical Indicators

RSI (14)64.0

MACD0.0243

MACD Signal0.0134

MACD Hist.+0.0108

BB Upper1.074 USD

BB Middle0.9701 USD

BB Lower0.8658 USD

BB Width21.51%

ATR (14)0.0448 USD

Vol Ratio (20d)1.43x